Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342703 · ClinicalTrials.gov registry record
Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI
A clinical trial of Liver Cirrhosis and Liver Steatoses, sponsored by Stanford University.
- Completed
- Registry status
- 35
- Enrollment target
- 2
- Study locations
NCT03342703 is a study of Liver Cirrhosis and Liver Steatoses that has completed, run by Stanford University. The registered enrollment target is 35 participants, below the 1,003-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03342703, a study of Liver Cirrhosis and Liver Steatoses, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators will assess the ability of ultrasound (US) to measure liver stiffness (cirrhosis) and liver fat content (steatosis).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound
Study Locations (2)
California
- Stanford University Hospital - Stanford
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03342703
The ClinicalTrials.gov registry entry for NCT03342703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,003-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (97% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Liver Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT03342703 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03342703 about?
NCT03342703 is a clinical study titled "Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI". The investigators will assess the ability of ultrasound (US) to measure liver stiffness (cirrhosis) and liver fat content (steatosis).
What is the current status of trial NCT03342703?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2018-08-01. Estimated completion is 2020-12-31.
What conditions does trial NCT03342703 study?
This clinical trial studies the following conditions: Liver Cirrhosis, Liver Steatoses.
What interventions are being tested in trial NCT03342703?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03342703?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03342703 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
RECRUITING
-
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RECRUITING · Phase 2
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.